Alveolar type II epithelial cell membrane

The alveolar type II epithelial cell membrane forms the outer boundary of alveolar type II cells (type II pneumocytes), which line a minority of the alveolar surface in the lung. These cells are central to synthesizing and secreting pulmonary surfactant, a lipid-protein mixture that reduces alveolar surface tension, preventing collapse of the air sacs during exhalation and ensuring efficient gas exchange[1][2][3][5][6]. Surfactant is produced intracellularly in lamellar bodies and secreted by exocytosis across this membrane. Alveolar type II cells also serve as progenitors for type I cells, contributing to epithelial repair after injury, regulate alveolar fluid balance, and have substantial roles in innate immune defense including production of antimicrobial peptides and presentation of antigens to immune cells[1][2][3][4][5].\n\nThis entry is not a typical drug target: it describes a cell membrane, not a discrete molecular entity (such as a receptor, enzyme, channel, etc.), so it is not targeted by drugs in the same way as classic pharmacological targets. Instead, surfactant replacement therapy (administered exogenously) treats the consequences of alveolar surfactant dysfunction, without targeting the membrane directly. However, molecules or drugs affecting surfactant synthesis, secretion, or the regenerative function of type II cells are of active research interest in pulmonary medicine[1][2][5][6].\n\nNote:\n- This is not a singular molecular target or canonical drug target and should not be listed as such.\n- For structured data relating to interacting drugs, mechanisms of action, or canonical target identifiers, refer to surfactant proteins or type II pneumocyte functional markers rather than the membrane interface as a whole.

Other names

Type II pneumocyte membranepulmonary surfactant-secreting cell membranegreat alveolar cell membrane